Drug Approval | July 08, 2022
Lupin’s Somerset manufacturing plant Receives EIR from US FDA
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
FDA changes inspection classification of the facility to Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
